{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:42:12Z","timestamp":1786635732644,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4103\/0019-5154.60347","type":"journal-article","created":{"date-parts":[[2010,3,20]],"date-time":"2010-03-20T01:24:40Z","timestamp":1269048280000},"page":"29","source":"Crossref","is-referenced-by-count":13,"title":["CTLA-4 A49G  gene polymorphism is not associated with vitiligo in South Indian population"],"prefix":"10.4103","volume":"55","author":[{"given":"Rabbani","family":"Syed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farha","family":"Deeba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jariya","family":"Quareen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MA","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiser","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanmanth","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-5154.60347-1","first-page":"363","volume-title":"Origin, clinical presentation, and diagnosis of hypomelanotic skin disorders","author":"Mollet","year":"2007","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/0019-5154.60347-2","first-page":"227","volume-title":"Autoimmune etiology of generalized vitiligo","author":"Le","year":"2008","journal-title":"Curr Dir Autoimmun"},{"key":"key-10.4103\/0019-5154.60347-3","doi-asserted-by":"crossref","unstructured":"Handa S, Kaur I. Vitiligo: clinical findings in 1436 patients, J\u2005Dermatol 1999;10:653-7.","DOI":"10.1111\/j.1346-8138.1999.tb02067.x"},{"key":"key-10.4103\/0019-5154.60347-4","unstructured":"Groysmane V, Sami N. Vitiligo e-medicine, dermatology, Disease of pigmentation Aug 2008."},{"key":"key-10.4103\/0019-5154.60347-5","first-page":"647","volume-title":"Vitiligo","author":"Kovacs","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.60347-6","unstructured":"Halder R, Taliaferro S. Vitiligo. In: Wolff K, Goldsmith L, Katz S, Gilchrest B, Paller A, Lefell D, eds. Fitzpatrick\u2032s Dermatology in General Medicine. Vol. 1. 7 th ed. 2008. p. 72."},{"key":"key-10.4103\/0019-5154.60347-7","first-page":"137","volume-title":"The genetic concept of vitiligo","author":"Zhang","year":"2005","journal-title":"J Dermatol Sci"},{"key":"key-10.4103\/0019-5154.60347-8","first-page":"244","volume-title":"The genetics of generalized vitiligo","author":"Spritz","year":"2008","journal-title":"Curr Dir Autoimmun"},{"key":"key-10.4103\/0019-5154.60347-9","unstructured":"Shajil EM, Chatterjee S, Agrawal D, Bagchi T, Begum R. Vitiligo: Pathomechanisms and genetic polymorphism of susceptibility genes, Indian J Exp Biol 2006;44:526-39."},{"key":"key-10.4103\/0019-5154.60347-10","first-page":"1","volume-title":"Immunological pathomechanisms in vitiligo","author":"Kemp","year":"2001","journal-title":"Expert Rev Mol Med"},{"key":"key-10.4103\/0019-5154.60347-11","first-page":"405","volume-title":"CTLA-4 can function as a negative regulator of T cell activation","author":"Walunas","year":"1994","journal-title":"Immunity"},{"key":"key-10.4103\/0019-5154.60347-12","unstructured":"Fattahi MJ, Pezeshki AM. Lack of Association between ctla0 -4 A49G Polymorphism and Vitiligo IJI v0 ol. 2 No. 2 Spring 2005."},{"key":"key-10.4103\/0019-5154.60347-13","first-page":"313","volume-title":"Exon-1 polymorphism of ctla0 -\u20054 gene in Iranian patients with Graves\u2032 disease","author":"Kalantari","year":"2003","journal-title":"Autoimmunity"},{"key":"key-10.4103\/0019-5154.60347-14","first-page":"4130","volume-title":"Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto\u2032s thyroiditis and Addison\u2032s disease","author":"Donner","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0019-5154.60347-15","first-page":"296","volume-title":"CTLA-0 4 polymorphisms in Spanish patients with rheumatoid arthritis","author":"Gonzalez-Escribano","year":"1999","journal-title":"Tissue Antigens"},{"key":"key-10.4103\/0019-5154.60347-16","first-page":"73","volume-title":"Analysis of a microsatellite polymorphism of the cytotoxic T-lymphocyte antigen-4 gene in patients with vitiligo","author":"Kemp","year":"1999","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.60347-17","first-page":"597","volume-title":"Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies","author":"Kikuoka","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/0019-5154.60347-18","first-page":"90","volume-title":"Evidence for an autoimmune pathogenesis of vitiligo","author":"Ongenae","year":"2003","journal-title":"Pigment Cell Res"},{"key":"key-10.4103\/0019-5154.60347-19","doi-asserted-by":"crossref","unstructured":"Bystryn JC. Theories on the pathogenesis of depigmentation: Immune hypothesis. In: Hann SK, Nordlund JJ, editors. Vitiligo. Oxford: Blackwell Science; 2000. p. 129-36.","DOI":"10.1002\/9780470760116.ch16"},{"key":"key-10.4103\/0019-5154.60347-20","first-page":"1061","volume-title":"Autoimmune melanocyte destruction in vitiligo","author":"van","year":"2001","journal-title":"Lab Invest"},{"key":"key-10.4103\/0019-5154.60347-21","first-page":"130","volume-title":"A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo","author":"Das","year":"2001","journal-title":"Trends Immunol"},{"key":"key-10.4103\/0019-5154.60347-22","doi-asserted-by":"crossref","unstructured":"Gauthier Y, Cario Andre M, Ta\u00efeb A. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 2003;16:322-32.","DOI":"10.1034\/j.1600-0749.2003.00070.x"},{"key":"key-10.4103\/0019-5154.60347-23","first-page":"149","volume-title":"An immunohistological study of cutaneous lymphocytes in vitiligo","author":"Badri","year":"1993","journal-title":"J Pathol"},{"key":"key-10.4103\/0019-5154.60347-24","first-page":"816","volume-title":"Presence or absence of melanocytes in vitiligo lesions: An immunohistochemical investigation","author":"Le","year":"1993","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0019-5154.60347-25","first-page":"171","volume-title":"Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion","author":"Le","year":"1997","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.60347-26","unstructured":"Vitiligo DJ. In: La pratique dermatologique. Vol. 4. Paris: Masson; 1904. p. 846-58."},{"key":"key-10.4103\/0019-5154.60347-27","first-page":"F41","volume-title":"Certified professionals: CD4(+)CD25(+) suppressor T cells","author":"Shevach","year":"2001","journal-title":"J Exp Med"},{"key":"key-10.4103\/0019-5154.60347-28","first-page":"295","volume-title":"Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation","author":"Read","year":"2000","journal-title":"J Exp Med"},{"key":"key-10.4103\/0019-5154.60347-29","first-page":"555","volume-title":"CD4(+)CD25(+) T-cell development is regulated by at least 2 distinct mechanisms","author":"Suto","year":"2002","journal-title":"Blood"},{"key":"key-10.4103\/0019-5154.60347-30","first-page":"6606","volume-title":"CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves\u2032 disease","author":"Kouki","year":"2000","journal-title":"J Immunol"},{"key":"key-10.4103\/0019-5154.60347-31","first-page":"21","volume-title":"CTLA-4 and its role in autoimmune thyroid disease","author":"Chistiakov","year":"2003","journal-title":"J Mol Endocrinol"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:49:35Z","timestamp":1786632575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0019-5154.60347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"alternative-id":["60347"],"URL":"https:\/\/doi.org\/10.4103\/0019-5154.60347","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}